1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle.
This review examines how genital herpes infections can be diagnosed. While symptoms may suggest herpes, laboratory tests are more reliable. The paper compares methods like nucleic acid amplification tests and serological assays. These tests detect the virus or antibodies in the blood. The review finds that nucleic acid tests are especially useful for active infections. Serological tests can show past exposure but may not tell the difference between HSV-1 and HSV-2. The authors suggest using multiple diagnostic tools for better accuracy. The findings do not propose new treatments but highlight the strengths and weaknesses of current methods.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Diagnosing genital herpes infections often relies on visual symptoms, but this approach has limitations. Clinical signs may be subtle or absent, especially in early stages. Prior research has shown that laboratory-based methods offer greater accuracy. These techniques can detect viral DNA or antibodies even when symptoms are not present. However, gaps remain in understanding which diagnostic tools are most effective in different clinical scenarios. No prior work had resolved the best practices for diagnosing herpes in asymptomatic individuals. That uncertainty drove the need for a comprehensive review of diagnostic methods. This gap motivated the current analysis of laboratory techniques for genital herpes detection.
Purpose Of The Study:
The aim of this review is to evaluate the effectiveness of diagnostic tools for genital herpes. Genital herpes is a common sexually transmitted infection caused by herpes simplex virus. Accurate diagnosis is essential for appropriate treatment and prevention. Current methods include clinical assessment and laboratory testing. However, clinical criteria alone may miss cases. This paper focuses on comparing laboratory techniques for diagnosing herpes. The motivation is to clarify which methods are most reliable in different contexts. This study does not propose new treatments or interventions. Instead, it synthesizes existing evidence on diagnostic accuracy.
The review suggests that nucleic acid amplification tests are more accurate than clinical criteria for diagnosing genital herpes.
Serological assays detect antibodies but may not distinguish between HSV-1 and HSV-2, according to the authors.
Clinical criteria may miss up to 30% of cases, especially in asymptomatic individuals, as noted in the review.
These tests detect viral DNA and are proposed as highly sensitive for active herpes infections.
Main Methods:
The review approach includes an analysis of diagnostic methods for herpes simplex virus. Techniques discussed include nucleic acid amplification tests and serological assays. These methods detect viral DNA or antibodies in patient samples. The applicability of each test is evaluated based on clinical scenarios. Limitations such as false negatives or cross-reactivity are also considered. The review does not include experimental data from new studies. Instead, it synthesizes findings from prior research. The goal is to provide a comprehensive overview of available diagnostic tools.
Main Results:
The strongest finding is that nucleic acid amplification tests are highly sensitive for detecting active herpes infections. Serological assays can confirm past exposure but may not distinguish between HSV-1 and HSV-2. Clinical criteria alone miss up to 30% of cases in some populations. False positives are more common with certain serological tests. The review suggests that combining clinical and laboratory methods improves diagnostic accuracy. No single method is universally superior in all cases. The evidence does not propose new diagnostic thresholds. Instead, it highlights the strengths and weaknesses of each approach.
Conclusions:
The authors propose that laboratory methods are more reliable than clinical criteria alone for diagnosing genital herpes. They suggest that nucleic acid amplification tests are particularly useful for detecting active infections. Serological testing may be less precise in distinguishing between HSV types. The review does not claim that one diagnostic method is essential in all cases. Instead, it emphasizes the importance of selecting the appropriate test based on clinical context. The findings do not suggest new treatment guidelines or interventions. The authors conclude that diagnostic accuracy depends on the method used and the patient’s symptoms. These conclusions are based solely on the evidence presented in the literature.
Serological assays may produce false positives and cannot always distinguish between HSV types.
The authors suggest that combining clinical and laboratory methods improves diagnostic accuracy.